PBIO — Pressure BioSciences Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.03m
- $28.64m
- $1.98m
Annual cashflow statement for Pressure BioSciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -11.7 | -16 | -20.2 | -16.1 | -29.3 |
| Depreciation | |||||
| Non-Cash Items | 3.79 | 6.97 | 15 | 8.46 | 21.9 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.42 | 4.03 | 0.202 | 3.02 | 4.14 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -6.33 | -4.88 | -4.87 | -4.48 | -3.19 |
| Capital Expenditures | -0.023 | -0.002 | -0.123 | -0.021 | -0.007 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | -0.795 | 0 | — | — |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.023 | -0.797 | -0.123 | -0.021 | -0.007 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 6.28 | 5.67 | 5.11 | 4.37 | 3.27 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.073 | -0.011 | 0.114 | -0.128 | 0.077 |